Home 禄 Metro 禄 Health and Science
Transgenic drugs could help hemophilia
Print Edition
SCIENTISTS are developing new drugs for treating hemophilia using transgenic technology at a research and development center in Songjiang District.
Zeng Fanyi, director of the Institute of Medical Genetics at the Shanghai Children’s Hospital, told the closing ceremony of the Shanghai Health and Science Week yesterday transgenic technology allowed the blood clotting factor Prothrombin Complex Concentrate be extracted for treating hemophilia.
Zeng is also a chief scientist with the National Basic Research Program of China.
Zeng said hemophiliacs are currently mainly treated by transfusing blood plasma clotting factors or the prothrombin complex.
But the sources of these blood products are limited and pose the risk of hepatitis infection. Foreign recombinant PCC products are expensive.
Zeng’s team has been doing research on extracting PCC from special transgenic milk for 20 years.
With transgenic technologies, scientists use the mammary glands of cows and ewes as a bioreactor and get milk containing special proteins, which can be recombined to form the pharmaceutical proteins people require.
They are now applying for the go-ahead for a clinical test and researching the commercialization of the “mammary gland bioreactor” technology.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔＄粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
